ArticleCureus2026
Gallbladder Perforation: A 23-Year Study of 100 Patients and Evolving Management Strategies.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGallbladder perforation (GBP) is an uncommon but clinically significant complication of gallstone disease, characterized by heterogeneous presentation, diagnostic ambiguity, and variable management strategies. Despite advances in imaging and surgical techniques, optimal treatment pathways remain ill-defined, particularly in distinguishing patients requiring urgent intervention from those suitable for conservative or delayed management.
methodsA retrospective analysis was conducted of 100 patients diagnosed with GBP at a single tertiary care center over a 23-year period (2002-2025). Clinical presentation, comorbidity profile, imaging findings, perforation subtype, management strategies, and outcomes were systematically evaluated. Patients were classified according to the modified Niemeier classification. Temporal trends in diagnosis, intervention, and surgical approach were analyzed to assess evolving management patterns. Data were analyzed descriptively to identify clinically meaningful patterns.
resultsThe cohort comprised 100 patients with a mean age of 61.1 years and a male predominance. Type II perforation was the most common subtype (62%), followed by Type III (34%) and combined Type II and III (4%), with no cases of Type I perforation observed. Preoperative diagnosis was achieved in 49% of cases, predominantly in Type II perforations, whereas Type III perforations were largely diagnosed intraoperatively. Imaging accuracy improved substantially in the later years of the study. Percutaneous drainage was required in 11% of patients and was employed selectively in those with persistent sepsis or significant collections. The majority of patients were managed with initial conservative treatment followed by interval surgery. A progressive shift toward laparoscopic surgery was observed over time, with improved feasibility and outcomes in delayed settings. Type III perforations were associated with increased operative complexity and a higher requirement for additional procedures. Occult malignancy was identified in 2% of patients.
conclusionGBP represents a spectrum of diseases requiring individualized, physiology-driven management. Most Type II perforations can be managed conservatively with selective intervention, while delayed surgery facilitates safer and more effective minimally invasive treatment. Type III perforation, although technically demanding, can often be managed electively in stable patients. These findings support a tailored approach that prioritizes sepsis control, appropriate patient selection, and optimal timing of surgery over routine early escalation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.